Dopamine transporter imaging with single-photon emission computed tomography may be considered medically necessary when used for individuals with:
clinically uncertain Parkinson disease; or
clinically uncertain dementia with Lewy bodies.
Use of dopamine transporter imaging with single-photon emission computed tomography is considered investigational for all other indications not included above.